Deferiprone Reduces Hemosiderin Deposits in the Brain of a Patient with Superficial Siderosis

References

1. 1.↵
   1. Levy M,
   2. Turtzo C,
   3. Llinas RH

   . Superficial siderosis: a case report and review of the literature. Nat Clin Pract Neurol 2007;3:54–58

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Kumar N

   . Neuroimaging in superficial siderosis: an in-depth look. AJNR Am J Neuroradiol 2010;31:5–14

   Abstract/FREE Full Text
3. 3.↵
   1. Kontoghiorghes GJ

   . Design, properties, and effective use of the oral chelator L1 and other alpha-ketohydroxypyridines in the treatment of transfusional iron overload in thalassemia. Ann N Y Acad Sci 1990;612:339–50

   CrossRefPubMed
4. 4.↵
   1. Fredenburg AM,
   2. Sethi RK,
   3. Allen DD,
   4. et al

   . The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1′ol]-2-methyl-3-hydroxypyridin-4-one in the rat. Toxicology 1996;30;108:191–99
5. 5.↵
   1. Koeppen AH,
   2. Dickson AC,
   3. Chu RC,
   4. et al

   . The pathogenesis of superficial siderosis of the central nervous system. Ann Neurol 1993;34:646–53

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kumar N,
   2. Lane JI,
   3. Piepgras DG

   . Superficial siderosos: sealing the defect. Neurology 2009;17;72:671–73

   FREE Full Text